The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Epizyme; Lilly

Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT.
 
Andrew J. Wagner
Honoraria - Novartis
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Five Prime Therapeutics; Lilly; Loxo
Research Funding - AADi (Inst); Daiichi Sankyo (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst)
 
Vinod Ravi
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Ignyta; Lilly; Loxo; NanoCarrier
Research Funding - AADi (Inst); Arog (Inst); Bayer (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); NanoCarrier (Inst); Plexxikon (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Ignyta; NanoCarrier
 
Kristen N. Ganjoo
Consulting or Advisory Role - Daiichi Sankyo; Foundation Medicine
 
Brian Andrew Van Tine
Leadership - Polaris
Consulting or Advisory Role - Adaptimmune; Bayer; Caris Life Sciences; CytRx Corporation; Daiichi Sankyo; EMD Serono; Epizyme; GlaxoSmithKline; Immune Design; Johnson & Johnson; Lilly/ImClone; Novartis; Pfizer; Plexxikon; Threshold Pharmaceuticals
Speakers' Bureau - Adaptimmune; Caris Life Sciences; GlaxoSmithKline; Johnson & Johnson; Lilly; Novartis
Research Funding - GlaxoSmithKline; Merck; Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; Lilly
 
Rashmi Chugh
Consulting or Advisory Role - Immune Design
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Epizyme (Inst); Lilly (Inst); MabVax (Inst); Morphotek (Inst); Mundipharma (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Travel, Accommodations, Expenses - SpringWorks Therapeutics
 
Lee D. Cranmer
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo; Regeneron
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); CBA Research (Inst); Exelixis (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Philogen (Inst)
 
Erlinda Maria Gordon
Research Funding - AADi
 
Jason L. Hornick
No Relationships to Disclose
 
David J. Kwiatkowski
Consulting or Advisory Role - Genentech/Roche; Novartis
Research Funding - AADi; Genentech/Roche; Revolution Medicines
 
Heng Du
No Relationships to Disclose
 
Berta Grigorian
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Anita N. Schmid
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Shihe Hou
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Katherine Harris
Employment - AADi
 
Neil Desai
Employment - AADi
Leadership - AADi
Stock and Other Ownership Interests - AADi
 
Mark Andrew Dickson
Consulting or Advisory Role - Celgene
Research Funding - AADi (Inst); Lilly (Inst)